Lubrizol Forms Alliance with Particle Sciences
The Lubrizol Corporation, Wickliffe, Ohio, USA, announces an alliance between Lubrizol LifeSciences, a supplier of advanced materials for the healthcare industry, and Particle Sciences, an integrated provider of drug development services. This alliance offers customers a comprehensive solution providing a range of materials, drug development and commercial manufacturing services that is one of the most comprehensive in the pharmaceutical industry.
Particle Sciences, based in Bethlehem, PA., is one of the world's leading contract drug development and manufacturing organizations (CDMO) with a comprehensive suite of services including analytic, bio-analytic, physical characterization and manufacturing, all focused on the formulation and support of advanced drug delivery solutions.
Lubrizol’s recent acquisition of Vesta, a contract manufacturer to the medical device industry, in combination with Lubrizol’s alliance with Particle Sciences, means that the LifeSciences business now offers complete solutions for sustained, controlled release and combination products from polymer supply and drug product development through quality manufacturing services.
“Teaming up with both Vesta and Particle Sciences enables Lubrizol to leverage our core polymer chemistry into tailored solutions for novel implantable and dermal drug delivery systems and combination products to deliver improved patient outcomes,” says Joey Glassco, global market manager for Lubrizol LifeSciences.
Would you like to subscribe to our Newsletters on plastics technology and profit from the latest information?
Looking for a new challenge? Check out our jobs market!
Patents encourage innovation: Stay on the ball with the latest innovations in the plastics industry in our patents section.